Changes in HbA1c and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study

被引:0
|
作者
Nicolucci, A. [1 ]
Chen, H. [2 ]
Fenici, P. [3 ]
Gomes, M. B. [4 ]
Saraiva, G. Luporini [2 ]
Medina, J. [5 ]
Pocock, S. [6 ]
Shestakova, M. V. [7 ]
Shimomura, I. [8 ]
Surmont, F. [9 ]
Tang, F. [10 ]
Vora, J. [11 ]
Watada, H. [12 ]
Khunti, K. [13 ]
Charbonnel, B. [14 ]
机构
[1] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[2] AstraZeneca, Gaithersburg, MD USA
[3] AstraZeneca, Cambridge, England
[4] Rio de Janerio State Univ, Rio De Janeiro, Brazil
[5] AstraZeneca, Madrid, Spain
[6] London Sch Hyg & Trop Med, London, England
[7] Diabet Inst, Endocrinol Res Ctr, Moscow, Russia
[8] Osaka Univ, Grad Sch Med, Osaka, Japan
[9] AstraZeneca, Luton, Beds, England
[10] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[11] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[12] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[13] Univ Leicester, Leicester, Leics, England
[14] Univ Nantes, Nantes, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
353
引用
收藏
页码:S176 / S177
页数:2
相关论文
共 50 条
  • [21] Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study
    Gomes, Marilia B.
    Tang, Fengming
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Khunti, Kamlesh
    Rathmann, Wolfgang
    Shestakova, Marina V.
    Surmont, Filip
    Watada, Hirotaka
    Medina, Jesus
    Shimomura, Iichiro
    Saraiva, Gabriela Luporini
    Cooper, Andrew
    Nicolucci, Antonio
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [23] Treatment patterns and associated factors in 13,379 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study
    Nicolucci, A.
    Arya, N.
    Charbonnel, B.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Khunti, K.
    Kosiborod, M.
    Shestakova, M. V.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Pocock, S.
    DIABETOLOGIA, 2017, 60 : S301 - S302
  • [24] Treatment Patterns and Associated Factors in 13,379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study
    Nicolucci, Antonio
    Arya, Nikita
    Charbonnel, Bernard
    Cidruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kamal, Samer
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Shestakova, Marina V.
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Pocock, Stuart
    DIABETES, 2017, 66 : A326 - A326
  • [25] Marked improvements in HbA1c following flashmonitor initiation in people with type 1 diabetes: a nationwide observational study in Scotland
    Gibb, F.
    Jeyam, A.
    McKnight, J.
    Kennon, B.
    McGurnaghan, S.
    Blackbourn, L. A. K.
    McKeigue, P.
    Colhoun, H. M.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S338 - S338
  • [26] HbA1c changes in patients with diabetes following periodontal therapy
    Kim, Su-Hwan
    Lee, Jihye
    Kim, Won-Kyung
    Lee, Young-Kyoo
    Kim, Young-Sung
    JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE, 2021, 51 (02): : 114 - 123
  • [27] Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study
    Bidulka, Patrick
    Mathur, Rohini
    Lugo-Palacios, David G.
    O'Neill, Stephen
    Basu, Anirban
    Silverwood, Richard J.
    Charlton, Paul
    Briggs, Andrew
    Smeeth, Liam
    Adler, Amanda, I
    Douglas, Ian J.
    Khunti, Kamlesh
    Grieve, Richard
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 282 - 292
  • [28] Prediction of HbA1c response to second-line anti-diabetic agents in type 2 diabetes using machine learning: preliminary results
    Stoltenberg, C. W.
    Hangaard, S.
    Hejlesen, O.
    Kronborg, T.
    Vestergaard, P.
    Jensen, M. H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S431 - S432
  • [29] Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in US Adults
    Raghavan, Sridharan
    Warsavage, Theodore
    Liu, Wenhui G.
    Raffle, Katherine
    Josey, Kevin
    Saxon, David R.
    Phillips, Lawrence S.
    Caplan, Liron
    Reusch, Jane E. B.
    DIABETES CARE, 2022, 45 (06) : 1335 - 1345
  • [30] Marked improvements in HbA1c levels following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
    Jeyam, A.
    Gibb, F.
    McKnight, J.
    Kennon, B.
    O'Reilly, J.
    McGurnaghan, S.
    Blackbourn, L. A. K.
    McKeigue, P. M.
    Colhoun, H. M.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S342 - S342